|
⚲
|
| Keyboard |
| Dickey Robert IV
✚
|
|
|---|---|
| CIK # | 0001466862 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001466862] | |
| 4 | [0001466862] | |
| 5 | [0001466862] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AngioGenex Inc AGGX
Stock Option · derivative
|
2021-09-02 | Grant | 250,000 | $0.13 | 32,500 |
|
Lisata Therapeutics Inc NBS
Common Stock, $0.001 par value
|
2014-12-31 | Grant | 484 | $3.20 | 1,549 |
|
Lisata Therapeutics Inc NBS
Common Stock, $0.001 par value
|
2014-08-01 | Grant | 6,303 | $0.00 | |
|
Lisata Therapeutics Inc NBS
Stock Option (right to purchase) · derivative
|
2014-08-01 | Grant | 25,000 | $0.00 | |
|
Lisata Therapeutics Inc NBS
Common Stock, $0.001 par value
|
2014-06-30 | Grant | 279 | $5.54 | 1,546 |
|
Lisata Therapeutics Inc NBS
Stock Option (right to purchase) · derivative
|
2014-01-02 | Grant | 35,000 | $0.00 | |
|
Lisata Therapeutics Inc NBS
Common stock, par value $0.001 per share
|
2013-08-19 | Grant | 5,000 | ||
|
Lisata Therapeutics Inc NBS
Stock Option (right to purchase) · derivative
|
2013-08-19 | Grant | 46,000 | $0.00 | |
|
Hemispherx Biopharma Inc HEB
Options to Buy Common Stock · derivative
|
2012-06-05 | Other | 50,000 | $0.00 |